Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 587

1.

Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors.

Damm O, Nocon M, Roll S, Vauth C, Willich S, Greiner W.

GMS Health Technol Assess. 2009 Mar 11;5:Doc04. doi: 10.3205/hta000066.

PMID:
21289891
[PubMed]
Free PMC Article
2.

Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany.

Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Siebert U.

GMS Health Technol Assess. 2010 Apr 27;6:Doc05. doi: 10.3205/hta000083.

PMID:
21289878
[PubMed]
Free PMC Article
3.

Cost-effectiveness evaluation of a quadrivalent human papillomavirus vaccine in Belgium.

Annemans L, Rémy V, Oyee J, Largeron N.

Pharmacoeconomics. 2009;27(3):231-45. doi: 10.2165/00019053-200927030-00006.

PMID:
19354343
[PubMed - indexed for MEDLINE]
4.
5.

Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.

Reynales-Shigematsu LM, Rodrigues ER, Lazcano-Ponce E.

Arch Med Res. 2009 Aug;40(6):503-13. doi: 10.1016/j.arcmed.2009.08.004.

PMID:
19853192
[PubMed - indexed for MEDLINE]
6.

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ.

BMC Infect Dis. 2013 Feb 7;13:75. doi: 10.1186/1471-2334-13-75.

PMID:
23390964
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Cost-effectiveness of different human papillomavirus vaccines in Singapore.

Lee VJ, Tay SK, Teoh YL, Tok MY.

BMC Public Health. 2011 Mar 31;11:203. doi: 10.1186/1471-2458-11-203.

PMID:
21453537
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan.

Dasbach EJ, Insinga RP, Yang YC, Pwu RF, Lac C, Elbasha EH.

Asian Pac J Cancer Prev. 2008 Jul-Sep;9(3):459-66.

PMID:
18990021
[PubMed - indexed for MEDLINE]
Free Article
9.

Cost-effectiveness analysis of adding a quadrivalent HPV vaccine to the cervical cancer screening programme in Switzerland.

Szucs TD, Largeron N, Dedes KJ, Rafia R, Bénard S.

Curr Med Res Opin. 2008 May;24(5):1473-83. doi: 10.1185/030079908X297826 . Epub 2008 Apr 14.

PMID:
18413014
[PubMed - indexed for MEDLINE]
10.

[Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].

Della Palma P, Moresco L, Giorgi Rossi P.

Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 3):e1-43. Italian.

PMID:
23139174
[PubMed - indexed for MEDLINE]
11.

A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females.

Anonychuk AM, Bauch CT, Merid MF, Van Kriekinge G, Demarteau N.

BMC Public Health. 2009 Oct 31;9:401. doi: 10.1186/1471-2458-9-401.

PMID:
19878578
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Falls prevention for the elderly.

Balzer K, Bremer M, Schramm S, Lühmann D, Raspe H.

GMS Health Technol Assess. 2012;8:Doc01. doi: 10.3205/hta000099. Epub 2012 Apr 12.

PMID:
22536299
[PubMed]
Free PMC Article
13.

Cost-effectiveness analysis of the bivalent compared with the quadrivalent human papillomavirus vaccines in Taiwan.

Demarteau N, Tang CH, Chen HC, Chen CJ, Van Kriekinge G.

Value Health. 2012 Jul-Aug;15(5):622-31. doi: 10.1016/j.jval.2012.02.012. Epub 2012 Jun 12.

PMID:
22867770
[PubMed - indexed for MEDLINE]
14.

Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [Internet].

Kulasingam SL, Havrilesky L, Ghebre R, Myers ER.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 May.

15.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

PMID:
17671238
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment.

Andersohn F, Bornemann R, Damm O, Frank M, Mittendorf T, Theidel U.

GMS Health Technol Assess. 2014 Oct 30;10:Doc03. doi: 10.3205/hta000119. eCollection 2014.

PMID:
25371764
[PubMed]
Free PMC Article
17.

Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER; Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24.

PMID:
17380109
[PubMed - indexed for MEDLINE]
Free Article
18.

Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model.

Schobert D, Remy V, Schoeffski O.

Health Econ Rev. 2012 Sep 25;2(1):19. doi: 10.1186/2191-1991-2-19.

PMID:
23009387
[PubMed]
Free PMC Article
19.

Prevention of relapsing backache.

Lühmann D, Stoll S, Burkhardt-Hammer T, Raspe H.

GMS Health Technol Assess. 2006 May 24;2:Doc12.

PMID:
21289963
[PubMed]
Free PMC Article
20.

Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease.

Müller-Riemenschneider F, Damm K, Meinhard C, Bockelbrink A, Vauth C, Willich SN, Greiner W.

GMS Health Technol Assess. 2009 Dec 14;5:Doc16. doi: 10.3205/hta000078.

PMID:
21289903
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk